TF
GSK icon

TIAA FSB’s GSK GSK Stock Holding History

TIAA FSB’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,469
Closed -$227K – 580
2022
Q4 		$227K Sell
6,469
-1,174
-15% -$39.1K ﹤0.01% 520
2022
Q3 		$225K Sell
7,643
-343
-4% -$13K ﹤0.01% 518
2022
Q2 		$435K Buy
+7,986
New +$441K ﹤0.01% 431
2021
Q3 		– Sell
-9,002
Closed -$448K – 384
2021
Q2 		$448K Buy
9,002
+568
+7% +$27.3K ﹤0.01% 359
2021
Q1 		$377K Sell
8,434
-4,060
-32% -$184K ﹤0.01% 347
2020
Q4 		$575K Buy
+12,494
New +$574K ﹤0.01% 322
2020
Q3 		– Sell
-16,172
Closed -$824K – 274
2020
Q2 		$824K Sell
16,172
-1,041
-6% -$53.4K ﹤0.01% 248
2020
Q1 		$815K Sell
17,213
-6,369
-27% -$340K ﹤0.01% 236
2019
Q4 		$1.39M Buy
23,582
+481
+2% +$26.8K 0.01% 245
2019
Q3 		$1.23M Sell
23,101
-129
-0.6% -$6.64K 0.01% 244
2019
Q2 		$1.16M Buy
23,230
+1,619
+7% +$81.2K 0.01% 235
2019
Q1 		$1.13M Sell
21,611
-518
-2% -$25.9K 0.01% 255
2018
Q4 		$1.06M Sell
22,129
-140
-0.6% -$6.89K 0.01% 257
2018
Q3 		$1.12M Buy
22,269
+349
+2% +$17.7K 0.01% 271
2018
Q2 		$1.1M Sell
21,920
-1,473
-6% -$74.2K 0.01% 270
2018
Q1 		$1.14M Sell
23,393
-54
-0.2% -$2.52K 0.01% 270
2017
Q4 		$1.04M Sell
23,447
-4,400
-16% -$203K 0.01% 308
2017
Q3 		$1.41M Sell
27,847
-289
-1% -$14.7K 0.01% 276
2017
Q2 		$1.52M Buy
+28,136
New +$1.5M 0.01% 259

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TIAA FSB's GSK Position: Q1 2023 in Review

TIAA FSB sold out of GSK (GSK) in Q1 2023, closing a stake of 6,469 shares — an estimated $227K sold.

TIAA FSB first reported a position in GSK in Q2 2017 and held it in 19 quarters. The position peaked at $1.52M in Q2 2017. 809 funds tracked by Wall St. Rank hold GSK as of Q1 2023.

  • TIAA FSB reported no remaining GSK position as of Q1 2023 after selling out during the quarter.
  • TIAA FSB sold 6,469 GSK shares in Q1 2023, an estimated $227K.
  • TIAA FSB first reported a position in GSK in Q2 2017 and held it in 19 quarters.
  • TIAA FSB's GSK position peaked at $1.52M in Q2 2017.
  • 809 funds tracked by Wall St. Rank held GSK as of Q1 2023.

Based on TIAA FSB's 13F filing for Q1 2023, filed 19 Apr 2023.